文献速递艾滋病与性传播感染

CRF01_AE及其簇4与中国cART患者免疫恢复不良相关

CRF01_AE and CRF01_AE Cluster 4 Are Associated With Poor Immune Recovery in Chinese Patients Under Combination Antiretroviral Therapy.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该队列研究纳入853例接受cART的中国HIV-1感染者,评估病毒因素对免疫恢复的影响。结果显示,CRF01_AE及其簇4独立关联于较低的CD4水平、较慢的免疫恢复、较少患者达标及较长达标时间,其机制与较高比例的CXCR4嗜性病毒有关。

要点

  • CRF01_AE及簇4是cART免疫恢复不良的独立危险因素。
  • X4嗜性病毒比例较高可解释CRF01_AE及簇4感染者的免疫恢复不良。
  • 高X4病毒流行区应慎用CCR5抑制剂,建议将基因型/表型检测作为监测工具。

核心结论

  • CRF01_AE及其簇4与cART患者免疫恢复不良相关,归因于高比例的X4嗜性病毒。

研究设计与样本

  • 对853例接受cART的患者进行队列研究,评估病毒因素对宿主免疫恢复的影响。

主要发现

  • 除低基线CD4和高龄外,CRF01_AE及其簇4独立关联于较低CD4水平(P≤.003)、较慢免疫恢复(P≤.022)、较少患者达标(P<.001)和较长达标时间(P<.001)。
  • CRF01_AE及簇4感染者中X4病毒比例较高(P<.001),可解释其免疫恢复不良(P<.001)。
  • CRF01_AE支(P<.001)及其簇4(P≤.004)的氨基酸 exhibit 更强的X4受体结合倾向。

临床怎么用

  • 建议将HIV-1基因型和表型检测作为启动cART患者的监测工具。
  • 在高X4病毒流行区应慎用CCR5抑制剂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) clades and clusters have different epidemic patterns and phenotypic profiles. It is unclear if they also affect patients' immune recovery (IR) in combination antiretroviral therapy (cART). METHODS: We conducted a cohort study on 853 patients under cART for evaluating the impacts of viral factor on host IR. We used generalized estimating equations for factors affecting CD4 recovery, Kaplan-Meier curves for probability of achieving IR, and Cox hazards model for factors influencing IR capability. RESULTS: Besides low baseline CD4 and old age, CRF01_AE and its cluster 4 were independently associated with lower CD4 cell level (P ≤ .003), slower IR (P ≤ .022), fewer patients (P < .001), and longer time achieving IR (P < .001), compared with CRF07_BC and CRF01_AE cluster 5. Higher percentage of CXCR4 (X4) viruses in the CRF01_AE and cluster 4-infected patients, compared with their respective counterparts (P < .001), accounted for the poor IR in infected patients (P < .001). Finally, we revealed that greater X4 receptor binding propensity of amino acids was exhibited in CRF01_AE clade (P < .001) and its cluster 4 (P ≤ .004). CONCLUSIONS: Our study demonstrates that the CRF01_AE clade and cluster are associated with poor IR in patients under cART, which is ascribed to a high proportion of viruses with X4 tropism. HIV-1 genotyping and phenotyping should be used as a surveillance tool for patients initiating cART. CCR5 inhibitors should be used with caution in regions with high prevalence of X4 viruses.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ge Z, Feng Y, Li K, et al. CRF01_AE and CRF01_AE Cluster 4 Are Associated With Poor Immune Recovery in Chinese Patients Under Combination Antiretroviral Therapy. Clin Infect Dis. 2021. PMID: 32296820. doi:10.1093/cid/ciaa380

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。